| Name | Open Orphan |
|---|---|
| Epic | ORPH |
| Isin | GB00B9275X97 |
| Industry | Medical Equipment and Services |
| Latest share price | 10.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £67.09 | Debt ratio | n/a |
| Shares in issue | 670.93 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 2.78 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.01 | 52-week high / low | 8.75p / 24.20p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Open Orphan |
|---|---|
| Address | Queen Mary Innovation Centre, 42 New Road, London, United Kingdom, E1 2AX |
| Telephone | |
| Website | http://www.vennlifesciences.com |
| Director | Position |
|---|---|
| Mr Yamin Mo' Khan | CEO |
| Mr Leo Toole | CFO |
| Dr Elaine Sullivan | Non-Executive Director |
| Mr Brendan Buckley | Non-Executive Director |
| Mr Cathal Friel | Executive Chairman |
| Mr Martin Gouldstone | Independent Non-Executive Director |
| Assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Reporting date | 31/12/21 | 31/12/20 | 31/12/19 |
| Intangible asssets and goodwill | 6.22 | 6.13 | 2.88 |
| Investments and other non-current assets | 7 | 7.08 | n/a |
| Total non-current assets | 16.94 | 18.5 | 4.38 |
| Inventory / work in progress | 0.66 | 0.95 | n/a |
| Trade and other receivables | 8.94 | 9.81 | 3.62 |
| Cash and equivalents | 15.69 | 19.2 | 1.04 |
| Other current assets and asset held for resale | 0.04 | 0.08 | 0.01 |
| Total of all assets | 42.27 | 48.55 | 9.04 |
| Liabilities £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Short term liabilities | 20.7 | 24.03 | 5.16 |
| Long term liabilities | 0.9 | 2.21 | 1.02 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 21.59 | 26.25 | 6.19 |
| Net assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net assets | 20.68 | 22.3 | 2.85 |
| Equity £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Share capital | 0.67 | 0.73 | 0.32 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 25.21 | -17.99 | -7.2 |
| Share premium account | n/a | 44.48 | 15.21 |
| Total equity | 20.68 | 22.3 | 2.85 |
| Income £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 0.59 | -10.26 | -5.13 |
| Pre-tax profit | 0.28 | -10.98 | -5.81 |